| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/26/2020 | Viking Therapeutics, Inc. | VKTX | Sale | Common Stock | 148.7k | $8.11 | $1.2M | | 08/25/2020 |
| 08/26/2020 | Viking Therapeutics, Inc. | VKTX | Sale | Common Stock | 94.5k | $8.11 | $766.1k | | 08/25/2020 |
| 08/25/2020 | Viking Therapeutics, Inc. | VKTX | Sale | Common Stock | 70k | $8.02 | $561.6k | | 08/25/2020 |
| 09/25/2018 | Viking Therapeutics, Inc. | VKTX | Sale | Common Stock | 262.9k | $19.15 | $5M | | 07/13/2017 |
| 05/21/2018 | Viking Therapeutics, Inc. | VKTX | Other (disposition) | Convertible Note (convertible into Common Stock) | 1.9M | $1,916,509.00 | $3673006.7M | | 07/13/2017 |
| 07/13/2017 | Viking Therapeutics, Inc. | VKTX | Other (disposition) | Convertible Note (convertible into Common Stock) | 38.6k | $38,630.00 | $1492.3M | | 07/13/2017 |
| 04/13/2016 | Viking Therapeutics, Inc. | VKTX | Other (disposition) | Convertible Note (convertible into Common Stock) | 150k | $150,000.00 | $22500M | | 04/13/2016 |
| 04/13/2016 | Viking Therapeutics, Inc. | VKTX | Conversion | Common Stock | 960k | $1.25 | $1.2M | | 04/13/2016 |
| 04/13/2016 | Viking Therapeutics, Inc. | VKTX | Grant | Common Stock | 560k | $0.00 | $0 | | 04/13/2016 |
| 04/13/2016 | Viking Therapeutics, Inc. | VKTX | Conversion | Warrant (right to buy) | 960k | $1.50 | $1.4M | | 04/13/2016 |
| 04/13/2016 | Viking Therapeutics, Inc. | VKTX | Conversion | Convertible Note (convertible into Common Stock) | 600k | $1.25 | $750k | | 04/13/2016 |
| 04/13/2016 | Viking Therapeutics, Inc. | VKTX | Grant | Warrant (right to buy) | 560k | $1.50 | $840k | | 04/13/2016 |
| 05/28/2015 | Viking Therapeutics, Inc. | VKTX | Other (acquisition) | Common Stock | 228.1k | $0.00 | $0 | | 05/28/2015 |
| 05/28/2015 | Viking Therapeutics, Inc. | VKTX | Other (acquisition) | Common Stock | 228.1k | $0.00 | $0 | | 05/28/2015 |